(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 6.89% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.15%.
Xoma Royalty's revenue in 2026 is $48,555,000.On average, 5 Wall Street analysts forecast XOMA's revenue for 2026 to be $776,766,316, with the lowest XOMA revenue forecast at $635,040,136, and the highest XOMA revenue forecast at $862,509,338. On average, 3 Wall Street analysts forecast XOMA's revenue for 2027 to be $671,321,336, with the lowest XOMA revenue forecast at $644,985,173, and the highest XOMA revenue forecast at $691,060,917.
In 2028, XOMA is forecast to generate $782,221,664 in revenue, with the lowest revenue forecast at $751,546,305 and the highest revenue forecast at $805,234,454.